GB8523338D0 - Treatment of obesity - Google Patents

Treatment of obesity

Info

Publication number
GB8523338D0
GB8523338D0 GB858523338A GB8523338A GB8523338D0 GB 8523338 D0 GB8523338 D0 GB 8523338D0 GB 858523338 A GB858523338 A GB 858523338A GB 8523338 A GB8523338 A GB 8523338A GB 8523338 D0 GB8523338 D0 GB 8523338D0
Authority
GB
United Kingdom
Prior art keywords
diet
tryptophan
daily
composition
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858523338A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kreitzman S N
Original Assignee
Kreitzman S N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kreitzman S N filed Critical Kreitzman S N
Priority to GB858523338A priority Critical patent/GB8523338D0/en
Publication of GB8523338D0 publication Critical patent/GB8523338D0/en
Priority to PCT/GB1986/000560 priority patent/WO1987001590A1/en
Priority to EP86905379A priority patent/EP0238533A1/en
Priority to GB08622618A priority patent/GB2180747A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Treatment of obesity, especially in man. In the invention an overweight patient is given a daily diet in which the amount of proteinaceous material is restricted below the patient's normal average daily intake of protein, together with a daily dose of at least about 0.5 grams of L-tryptophan as appetite-suppressant. Thus, the invention provides a composition for use in the treatment of obesity. That composition comprises L-tryptophan and a protein-restricted diet composition as carrier, the amount of L-tryptophan in the composition being such as to provide at least about 0.5 grams of L-tryptophan per daily amount of diet. Preferably, the carrier is a protein-restricted formula diet, the diet comprising on a daily amount basis less than about 100 grams of proteinaceaous material and an energy level of no more than about 1000 Kcals.
GB858523338A 1985-09-20 1985-09-20 Treatment of obesity Pending GB8523338D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB858523338A GB8523338D0 (en) 1985-09-20 1985-09-20 Treatment of obesity
PCT/GB1986/000560 WO1987001590A1 (en) 1985-09-20 1986-09-19 A composition and pack for use in the treatment of obesity
EP86905379A EP0238533A1 (en) 1985-09-20 1986-09-19 A composition and pack for use in the treatment of obesity
GB08622618A GB2180747A (en) 1985-09-20 1986-09-19 Tryptophan composition for treatment of obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858523338A GB8523338D0 (en) 1985-09-20 1985-09-20 Treatment of obesity

Publications (1)

Publication Number Publication Date
GB8523338D0 true GB8523338D0 (en) 1985-10-23

Family

ID=10585524

Family Applications (2)

Application Number Title Priority Date Filing Date
GB858523338A Pending GB8523338D0 (en) 1985-09-20 1985-09-20 Treatment of obesity
GB08622618A Withdrawn GB2180747A (en) 1985-09-20 1986-09-19 Tryptophan composition for treatment of obesity

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB08622618A Withdrawn GB2180747A (en) 1985-09-20 1986-09-19 Tryptophan composition for treatment of obesity

Country Status (3)

Country Link
EP (1) EP0238533A1 (en)
GB (2) GB8523338D0 (en)
WO (1) WO1987001590A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2648044A1 (en) * 1989-06-07 1990-12-14 Norchim Liquid pharmaceutical composition exhibiting anorexigenic activity
FR2657013B1 (en) * 1990-01-18 1992-05-15 Medgenix Group Sa DIETETIC COMPOSITION BASED ON POLYPEPTIDES AND AMINO ACIDS.
ES2087027B1 (en) * 1994-08-03 1997-02-01 Univ Illes Balears NUTRITIONAL THERMOGENETIC SUPPLEMENTS, FOODS THAT CONTAIN THEM AND APPLICATIONS.
GB9416921D0 (en) * 1994-08-22 1994-10-12 Conway Gitta C A nutritional preparation
US6013622A (en) * 1998-04-15 2000-01-11 Nutriceutical Technology Corporation Method of regulating appetite and metabolism
AU3525299A (en) * 1998-04-23 1999-11-16 Pro Dietic Rdp (S.A.R.L.) Protein supplement, food composition containing same, preparation method and use
FR2777751B1 (en) * 1998-04-23 2001-11-02 Pro Dietic Rdp PROTEIN SUPPLEMENT, FOOD COMPOSITION CONTAINING THE SAME, PROCESS FOR THEIR PREPARATION AND THEIR USE.
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
DK0951842T3 (en) 1999-01-20 2003-01-06 Nutricia Nv Nutritional product for an infant
PT1153548E (en) 2000-05-12 2007-08-08 Nattopharma Asa Vitamin k2 containing food product
GB0220182D0 (en) 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
ATE477812T1 (en) * 2003-02-07 2010-09-15 Campina Bv USE OF TRYPTOPHAN-RICH PEPTIDES FROM WHEY PROTEIN HYDROLYSATES TO TREAT OVERWEIGHT AND OBESITY
ITTO20070391A1 (en) * 2007-06-05 2008-12-06 Medestea Res & Production S P COMPOSITION OF FOOD SUPPLEMENT, DRUG OR MEDICAL DEVICE AND ITS USE TO SUPPRESS THE APPETITE, IMPROVING TONE AND HUMOR, WITH NATURAL ANTIDEPRESSIVE ACTIVITY AND ANTI-STASTENIC EFFECT
EP3518688A1 (en) * 2016-09-29 2019-08-07 Société des Produits Nestlé S.A. Methods that reduce food cravings, promote weight loss, and/or treat overweight or obesity
CN114631629A (en) * 2020-12-15 2022-06-17 中国科学院上海营养与健康研究所 A method for treating obesity with low protein content

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150044A (en) * 1962-04-18 1964-09-22 Sam I Stein Treatment and composition for high blood pressure and palpitation
GB1289096A (en) * 1968-10-03 1972-09-13
US3809752A (en) * 1971-03-24 1974-05-07 W Fishman Anti-obesity process
DE2305209A1 (en) * 1972-02-14 1973-08-23 Hoffmann La Roche PHARMACEUTICAL PREPARATION
GB1356370A (en) * 1972-03-06 1974-06-12 Howard A N Methods and formulations for the treatment of obesity
US4298601A (en) * 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US4377595A (en) * 1979-08-13 1983-03-22 Massachusetts Institute Of Technology Process for reducing depression
DK198583A (en) * 1982-05-20 1983-11-21 Showa Denko Kk PIG FEED
GB2129299A (en) * 1982-11-09 1984-05-16 Alec James Coppen Pharmaceutical compositions
CH658165A5 (en) * 1984-01-04 1986-10-31 Nestle Sa FOOD PRODUCT EFFECTIVE IN THE TREATMENT OF LEPROSY.

Also Published As

Publication number Publication date
GB8622618D0 (en) 1986-10-22
GB2180747A (en) 1987-04-08
WO1987001590A1 (en) 1987-03-26
EP0238533A1 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
GB8622618D0 (en) Treatment of obesity
NZ334635A (en) Treatment of autoimmune diseases such as rheumatoid arthritis with a vaccine
FI970747A (en) Combination product for use in immunological diseases
AU678795B2 (en) Application of riluzole in the treatment of neurological lesions related to traumatic injuries
GR3036901T3 (en) Treatment of partial growth hormone insensitivity syndrome
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
EP0342956A3 (en) Use of phytic acid or its salts for the treatment of hyperlipemia, obesity and obesity-related diseases
EA200000506A1 (en) COMPOSITION TO REDUCE WEIGHT
PL325865A1 (en) Selective antagonists of beta3-adrenergic receptor
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
GR3003750T3 (en)
EP0167995A3 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
JPS57126420A (en) Drug for digestive organ
EP0264953A3 (en) Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use
EP0946174A4 (en) Treatment of urinary incontinence and compositions for use therein
GB9617611D0 (en) Treatment of autoimmune disease
BG49742A1 (en) Affrodisiance means
UA10249A (en) Method for treating diabetic angiopathy
GR950100380A (en) Natural ointment for pharmaceutical and cosmetical use
UA10764A (en) Method for treating diabetes mellitus and its vascular complications in patients exposed to ionizing radiation
UA19610A (en) Method for treatment of opisthorchiasis invasion
PT82535B (en) Pharmacologically active propionylanilides
UA10248A (en) Method for treating ischemic heart disease in the setting of diabetes mellitus
IT1261863B (en) Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration